http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112017020556-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d883490d0c299d26cc11eddddbbed1ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_916075766043ce900399a4c2eee9f054
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-06
filingDate 2016-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f722d3e91e441f57cff6f8e8f3b279f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d97efc1a62d7543c4eb3db7c60e338b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f5ac2fb4b96f7a29b0e5ea157a93d02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d36cffc16c578051a25af97f727753c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31afbc454aeca7196a6c96fc9f5747ad
publicationDate 2018-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-112017020556-A2
titleOfInvention triazolopyrimidine derivative, pharmaceutical composition, method of preparing a compound, intermediate, and method of prevention and / or treatment in a patient.
abstract The invention relates to the use of triazolopyrimidine derivatives in the manufacture of a medicament for preventing or treating malaria. Specifically, the present invention relates to triazolopyrimidine derivatives useful in the preparation of a pharmaceutical formulation for inhibiting malaria parasite proliferation.
priorityDate 2015-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481482
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5327131

Total number of triples: 27.